Systematic review / meta-analysis / 2021
Evidence on caffeine's impact on bipolar disorder is inconclusive, though case reports note switches to mania and altered lithium levels.
A systematic review was conducted across PubMed, Embase, and PsycINFO to assess whether caffeine intake or withdrawal impacts clinical outcomes in bipolar disorder. Out of 1,678 records reviewed, 17 studies met inclusion criteria. Most case reports noted patients switching to manic, hypomanic, or mixed states after variable caffeine intake, or showed increased serum lithium concentrations after reducing caffeine. The interventional study found caffeine may suppress lithium concentrations, and a retrospective cohort found coffee drinkers had more suicidality than non-drinkers; overall, the literature remains inconclusive.
Shows an association, not proof of cause and effect.
- Study type
- Systematic review
- Who was studied
- Individuals with bipolar disorder across 17 studies (10 case reports, 1 retrospective cohort, 5 cross-sectional, 1 interventional)
- What was measured
- Illness severity including symptoms of mania, depression, psychosis, anxiety, sleep, suicidality, and lithium levels
THE PAPER
The impact of caffeine consumption on clinical symptoms in patients with bipolar disorder: A systematic review.
Frigerio S, Strawbridge R, Young AH. Bipolar Disord, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.